Skip to main content
    G

    Galapagos NV ADR (GLPG)

    Official site

    BIOTECHNOLOGY

    $27.73
    -1.08 (-3.75%)

    Last updated: May 07, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    74%(28/38)
    Avg Surprise
    +113.05%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$-6.24
    Range$-11.71 - $-0.77
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.28-2328.6%
    60d ago$0.28-2328.6%
    30d ago$-0.57-985.2%
    7d ago$-0.57-985.2%
    Current$-6.24
    Revenue Consensus
    $33M
    Range$12M - $75M
    3 analysts
    Period ending Sep 30, 2026
    EPS Consensus$-0.77
    Range$-0.87 - $-0.66
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.41-288.9%
    60d ago$0.41-288.9%
    30d ago$-0.56-36.6%
    7d ago$-0.56-36.6%
    Current$-0.77
    Revenue Consensus
    $33M
    Range$11M - $75M
    3 analysts
    Last 12 of 38 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$4.88$0.73 - $7.17--3--
    Sep 26EST
    		-$-0.77$-0.87 - $-0.66--2
    0
    2
    30d
    		-
    Jun 26EST
    		-$-6.24$-11.71 - $-0.77--2
    0
    2
    30d
    		-
    Mar 26
    Reported May 6
    		$0.25N/A-+119.69%Beat2
    1
    0
    30d
    		+110.1%
    Dec 25
    Reported Feb 23
    		$16.38$1.00$-0.93 - $4.72+1538.00%Beat3-+4078.6%
    Sep 25
    Reported Nov 5
    		$-3.59$-0.20$-0.56 - $0.20-1696.36%Miss4
    1
    0
    30d
    		-366.6%
    Jun 25
    Reported Jul 23
    		$-1.89$-0.67$-0.87 - $-0.31-182.27%Miss6
    No revisions (30d)
    		-1450.9%
    Mar 25
    Reported Apr 23
    		$-2.47$-0.23$-0.40 - $0.04-973.91%Miss5
    1
    1
    30d
    		-733.3%
    Dec 24
    Reported Feb 28
    		$0.39$-0.24$-0.54 - $-0.13+263.33%Beat5
    0
    1
    30d
    		-83.6%
    Sep 24
    Reported Oct 30
    		$-0.77$-0.27$-0.85 - $0.12-185.19%Miss4
    No revisions (30d)
    		-297.4%
    Jun 24
    Reported Sep 12
    		$0.14$0.03$-0.29 - $0.21+450.10%Beat2
    No revisions (30d)
    		+75.0%
    Mar 24
    Reported May 2
    		$0.39$-0.12$-0.32 - $0.02+425.00%Beat3
    1
    0
    30d
    		+1.2%
    Dec 23
    Reported Feb 23
    		$2.39$-1.18$-4.90 - $0.03+302.54%Beat5
    No revisions (30d)
    		+175.6%
    Sep 23
    Reported Nov 3
    		$0.39$-0.62$-1.47 - $-0.22+162.90%Beat4
    No revisions (30d)
    		+18.2%
    Jun 23
    Reported Aug 3
    		$0.08N/A-+111.43%Beat6
    No revisions (30d)
    		+127.6%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$28.26
    SMA 20$28.59
    SMA 50$30.32
    SMA 200$32.15
    EMA 10$28.34
    EMA 20$28.69
    EMA 50$29.94
    EMA 200$31.02

    MACD

    Line: -0.56Signal: -0.65Hist: 0.08

    ADX

    ADX: 24.4+DI: 15.9-DI: 37.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$28.97

    Bollinger Bands

    Upper Band$29.53
    Lower Band$27.64
    %B Position660%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    36.5

    Momentum Oscillators

    Stoch %K46.3
    Stoch %D47.2
    Williams %R-74.9
    ROC (10d)-3.3%
    Momentum-0.95
    CCI (20d)-140.1
    MFI (14d)38.9

    Volatility Measures

    ATR (14d)$0.72(2.6%)
    StdDev (20d)0.47
    Hist Vol21.2%(Moderate)

    Volume Flow

    VWAP$27.81
    OBV1.9M
    AD Line1.9M
    CMF (20d)-0.102

    Volume Metrics

    Avg Vol (20d)144.8K
    Vol Ratio2.0x(High)
    VWMA (20d)$28.47

    Pivot Points

    R3$29.34
    R2$29.16
    R1$28.98
    Pivot Point$28.80
    S1$28.62
    S2$28.44
    S3$28.26

    Advanced Oscillators

    TSI-23.65
    Ultimate Osc46.5
    KST-63.02

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$6.48M$900.82M$71.16M$65.29M$74.98M$75.50M$59.85M$77.87M$62.43M$-209,124,000$120.03M$149.95M
    Cost of Revenue$4.80M$455,000$10.85M$4.71M$13.73M$112.93M$19,000$16.56M$2.55M$84.43M$5.70M$4.27M
    Gross Profit$1.68M$900.37M$60.31M$60.58M$61.25M$-37,433,000$59.83M$61.32M$59.88M$-209,124,000$114.33M$145.69M
    Operating Expenses$65.39M$141.57M$306.74M$117.61M$219.96M$25.29M$114.14M$99.50M$93.02M$-139,815,000$144.56M$156.38M
    R&D$30.96M$107.51M$73.88M$95.28M$182.75M$573.73M$93.05M$73.61M$71.61M$-70,886,000$100.31M$108.35M
    SG&A$35.51M$2.94M$34.55M$18.80M$43.80M$41.25M$46.58M$15.83M$30.79M$-87,917,000$84.66M$39.41M
    Operating Income$-63,703,000$758.80M$-246,425,000$-57,027,000$-158,708,000$-62,721,000$-54,305,000$-38,181,000$-33,131,000$-69,309,000$-30,233,000$-10,690,000
    Interest Income$0$0$0$9.95M$12.56M$18.71M$23.13M$23.71M$25.71M$27.69M$21.71M$20.05M
    Interest Expense$139,252$970,719$23.52M$661,936$780,000$97,000$275,000$285,000$254,000$0$286,101$782,000
    Income Before Tax$13.96M$783.15M$-221,493,000$-104,424,000$-156,367,000$19.03M$-49,141,000$4.09M$22.93M$-62,023,000$25.73M$18.46M
    Income Tax Expense$70,000$666,000$-17,499,000$26,000$-1,814,000$-93,000$-571,000$-571,000$-568,000$-3,897,000$-100,000$13.36M
    Net Income$14.49M$782.15M$-202,111,000$-105,748,000$-153,403,000$25.31M$-50,430,000$8.98M$90.22M$157.56M$25.83M$5.10M
    EBITDA$-63,703,000$560.50M$-189,533,000$-101,118,000$-158,708,000$-53,871,000$-152,761,000$78.43M$23.19M$-65,020,000$29.82M$35.53M
    EBIT$-63,703,000$560.50M$-197,977,000$-101,118,000$-158,708,000$-62,721,000$-152,761,000$60.27M$23.19M$-65,020,000$29.82M$16.96M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GLPG

    News

    No news available

    Company news will appear here when available

    GLPG Competitors

    CompanyTicker
    AMN Healthcare Services IncAMN
    Trevi Therapeutics IncTRVI
    Certara IncCERT
    Omnicell IncOMCL
    Vir Biotechnology IncVIR
    Sonida Senior Living IncSNDA
    BioLife Solutions IncBLFS
    Teladoc IncTDOC

    Sector: Healthcare

    GLPG Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -83.3%
    EPS estimate (fiscal period ending Jun 30, 2026)
    $-6.24
    Estimate revisions (30 days, fiscal period ending Jun 30, 2026)
    0 up, 2 down

    GLPG Earnings Call

    The latest GLPG earnings call transcript on file is labeled 2025Q4.

    Read the 2025Q4 transcript

    Frequently Asked Questions About GLPG

    Does GLPG pay dividends?

    Galapagos NV ADR (GLPG) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In